These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7586185

  • 1. Human CYP2D6 gene polymorphism in Slovene cancer patients and healthy controls.
    Dolzan V, Rudolf Z, Breskvar K.
    Carcinogenesis; 1995 Nov; 16(11):2675-8. PubMed ID: 7586185
    [Abstract] [Full Text] [Related]

  • 2. Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer.
    Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Sorsa M, Vainio H.
    Pharmacogenetics; 1992 Dec; 2(6):259-63. PubMed ID: 1306126
    [Abstract] [Full Text] [Related]

  • 3. PCR-based CYP2D6 genotyping for Finnish lung cancer patients.
    Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Pelkonen O, Vainio H.
    Pharmacogenetics; 1993 Feb; 3(1):19-27. PubMed ID: 8097947
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.
    Roots I, Brockmöller J, Drakoulis N, Loddenkemper R.
    Clin Investig; 1992 Feb; 70(3-4):307-19. PubMed ID: 1355678
    [Abstract] [Full Text] [Related]

  • 8. Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.
    Saxena R, Shaw GL, Relling MV, Frame JN, Moir DT, Evans WE, Caporaso N, Weiffenbach B.
    Hum Mol Genet; 1994 Jun; 3(6):923-6. PubMed ID: 7951238
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity.
    Romkes-Sparks M, Mnuskin A, Chern HD, Persad R, Fleming C, Sibley GN, Smith P, Wilkinson GR, Branch RA.
    Carcinogenesis; 1994 Sep; 15(9):1955-61. PubMed ID: 7923590
    [Abstract] [Full Text] [Related]

  • 12. Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls.
    Tefre T, Daly AK, Armstrong M, Leathart JB, Idle JR, Brøgger A, Børresen AL.
    Pharmacogenetics; 1994 Apr; 4(2):47-57. PubMed ID: 8081413
    [Abstract] [Full Text] [Related]

  • 13. Debrisoquin oxidation genotype and susceptibility to lung cancer.
    Agúndez JA, Martínez C, Ladero JM, Ledesma MC, Ramos JM, Martín R, Rodriguez A, Jara C, Benítez J.
    Clin Pharmacol Ther; 1994 Jan; 55(1):10-4. PubMed ID: 8299311
    [Abstract] [Full Text] [Related]

  • 14. Debrisoquine hydroxylase gene polymorphism in meningioma.
    Wundrack I, Meese E, Müllenbach R, Blin N.
    Acta Neuropathol; 1994 Jan; 88(5):472-4. PubMed ID: 7847077
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility.
    Wolf CR, Smith CA, Gough AC, Moss JE, Vallis KA, Howard G, Carey FJ, Mills K, McNee W, Carmichael J.
    Carcinogenesis; 1992 Jun; 13(6):1035-8. PubMed ID: 1600608
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU, Asante-Poku S, Ofori-Adjei D, Mikus G, Eichelbaum M.
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [Abstract] [Full Text] [Related]

  • 19. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
    Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ.
    Am J Hum Genet; 1989 Dec; 45(6):889-904. PubMed ID: 2574001
    [Abstract] [Full Text] [Related]

  • 20. An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution.
    Daly AK, Leathart JB, London SJ, Idle JR.
    Hum Genet; 1995 Mar; 95(3):337-41. PubMed ID: 7868129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.